Hormonal	O
regulation	O
and	O
distinct	O
functions	O
of	O
semaphorin	O
-	O
3B	O
and	O
semaphorin	O
-	O
3F	O
in	O
ovarian	B-Cancer
cancer	I-Cancer
.	O

Semaphorins	O
comprise	O
a	O
family	O
of	O
molecules	O
that	O
influence	O
neuronal	B-Cell
growth	O
and	O
guidance	O
.	O

Class	O
-	O
3	O
semaphorins	O
,	O
semaphorin	O
-	O
3B	O
(	O
SEMA3B	O
)	O
and	O
semaphorin	O
-	O
3F	O
(	O
SEMA3F	O
)	O
,	O
illustrate	O
their	O
effects	O
by	O
forming	O
a	O
complex	O
with	O
neuropilins	O
(	O
NP	O
-	O
1	O
or	O
NP	O
-	O
2	O
)	O
and	O
plexins	O
.	O

We	O
examined	O
the	O
status	O
and	O
regulation	O
of	O
semaphorins	O
and	O
their	O
receptors	O
in	O
human	O
ovarian	B-Cell
cancer	I-Cell
cells	I-Cell
.	O

A	O
significantly	O
reduced	O
expression	O
of	O
SEMA3B	O
(	O
83	O
kDa	O
)	O
,	O
SEMA3F	O
(	O
90	O
kDa	O
)	O
,	O
and	O
plexin	O
-	O
A3	O
was	O
observed	O
in	O
ovarian	B-Cell
cancer	I-Cell
cell	I-Cell
lines	I-Cell
when	O
compared	O
with	O
normal	O
human	O
ovarian	B-Cell
surface	I-Cell
epithelial	I-Cell
cells	I-Cell
.	O

The	O
expression	O
of	O
NP	O
-	O
1	O
,	O
NP	O
-	O
2	O
,	O
and	O
plexin	O
-	O
A1	O
was	O
not	O
altered	O
in	O
human	O
ovarian	B-Cell
surface	I-Cell
epithelial	I-Cell
and	O
ovarian	B-Cell
cancer	I-Cell
cells	I-Cell
.	O

The	O
decreased	O
expression	O
of	O
SEMA3B	O
,	O
SEMA3F	O
,	O
and	O
plexin	O
-	O
A3	O
was	O
confirmed	O
in	O
stage	O
3	O
ovarian	B-Cancer
tumors	I-Cancer
.	O

The	O
treatment	O
of	O
ovarian	B-Cell
cancer	I-Cell
cells	I-Cell
with	O
luteinizing	O
hormone	O
,	O
follicle	O
-	O
stimulating	O
hormone	O
,	O
and	O
estrogen	O
induced	O
a	O
significant	O
upregulation	O
of	O
SEMA3B	O
,	O
whereas	O
SEMA3F	O
was	O
upregulated	O
only	O
by	O
estrogen	O
.	O

Cotreatment	O
of	O
cell	B-Cell
lines	I-Cell
with	O
a	O
hormone	O
and	O
its	O
specific	O
antagonist	O
blocked	O
the	O
effect	O
of	O
the	O
hormone	O
.	O

Ectopic	O
expression	O
of	O
SEMA3B	O
or	O
SEMA3F	O
reduced	O
soft	O
-	O
agar	O
colony	B-Cell
formation	O
,	O
adhesion	O
,	O
and	O
cell	B-Cell
invasion	O
of	O
ovarian	B-Cell
cancer	I-Cell
cell	I-Cell
cultures	I-Cell
.	O

Forced	O
expression	O
of	O
SEMA3B	O
,	O
but	O
not	O
SEMA3F	O
,	O
inhibited	O
viability	O
of	O
ovarian	B-Cell
cancer	I-Cell
cells	I-Cell
.	O

Overexpression	O
of	O
SEMA3B	O
and	O
SEMA3F	O
reduced	O
focal	O
adhesion	O
kinase	O
phosphorylation	O
and	O
matrix	O
metalloproteinase	O
-	O
2	O
and	O
matrix	O
metalloproteinase	O
-	O
9	O
expression	O
in	O
ovarian	B-Cell
cancer	I-Cell
cells	I-Cell
.	O

Forced	O
expression	O
of	O
SEMA3F	O
,	O
but	O
not	O
SEMA3B	O
in	O
ovarian	B-Cell
cancer	I-Cell
cells	I-Cell
,	O
significantly	O
inhibited	O
endothelial	B-Tissue
cell	I-Tissue
tube	I-Tissue
formation	O
.	O

Collectively	O
,	O
our	O
results	O
suggest	O
that	O
the	O
loss	O
of	O
SEMA3	O
expression	O
could	O
be	O
a	O
hallmark	O
of	O
cancer	B-Cancer
progression	O
.	O

Furthermore	O
,	O
gonadotropin	O
-	O
and	O
/	O
or	O
estrogen	O
-	O
mediated	O
maintenance	O
of	O
SEMA3	O
expression	O
could	O
control	O
ovarian	B-Cancer
cancer	I-Cancer
angiogenesis	O
and	O
metastasis	O
.	O

